Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Beird HC"'
Autor:
Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cloutier JM; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gokgoz N; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Toronto, ON, Canada., Eeles C; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada., Griffin AM; University of Toronto Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Canada., Ingram DR; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wani KM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Segura RL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cohen L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ho C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wunder JS; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Toronto, ON, Canada; University of Toronto Musculoskeletal Oncology Unit, Mount Sinai Hospital, Toronto, Canada., Andrulis IL; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital Toronto, ON, Canada; Department of Molecular Genetics Canada & Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haibe-Kains B; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada; Department of Medical Biophysics, University of Toronto, & Vector Institute for Artificial Intelligence, Toronto, ON, Canada., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Przybyl J; Department of Surgery, McGill University & Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Demicco EG; Department of Pathology & Laboratory Medicine, Mount Sinai Hospital & Department of Laboratory Medicine and pathobiology, University of Toronto, Toronto, ON, Canada. Electronic address: Elizabeth.demicco@sinaihealth.ca.
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2024 Sep 30, pp. 102146. Date of Electronic Publication: 2024 Sep 30.
Autor:
Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang Z; Pediatric Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ju Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kolb EA; Nemours Center for Cancer and Blood Disorders, Alfred I. DuPont Hospital for Children, Wilmington, DE, USA., Zhang W; Pediatric Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gill J; Pediatric Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ha M; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Health Informatics and Biostatistics, Yonsei University, Seoul, Korea., Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Houghton P; Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Morton CL; Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN, USA., Kurmasheva R; Greehey Children's Cancer Research Institute, San Antonio, TX, USA., Maris J; Children's Hospital of Philadelphia, Philadelphia, PA, USA., Mosse Y; Children's Hospital of Philadelphia, Philadelphia, PA, USA., Lu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gorlick R; Pediatric Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hccheung@mdanderson.org.
Publikováno v:
Scientific reports [Sci Rep] 2024 Aug 27; Vol. 14 (1), pp. 19891. Date of Electronic Publication: 2024 Aug 27.
Autor:
Nakazawa MS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Silverman IM; Repare Therapeutics, Cambridge, Massachusetts., Rimkunas V; Repare Therapeutics, Cambridge, Massachusetts., Veloso A; Repare Therapeutics, Cambridge, Massachusetts., Glodzik D; Repare Therapeutics, Cambridge, Massachusetts., Johnson A; Repare Therapeutics, Cambridge, Massachusetts., Ohsumi TK; Repare Therapeutics, Cambridge, Massachusetts., Patel SR; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Conley AP; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ingram DR; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazcano R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Song D; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wani KM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lazar AJ; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yap TA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Livingston JA; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Jul 02; Vol. 23 (7), pp. 1057-1065.
Autor:
Fang H; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Wang SA; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Tang Z; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., You MJ; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Li S; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Xu J; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Hu S; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Yin CC; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., El Hussein S; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Lin P; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Jelloul FZ; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Vega F; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Medeiros LJ; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US., Wang W; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Publikováno v:
American journal of clinical pathology [Am J Clin Pathol] 2024 Jun 30. Date of Electronic Publication: 2024 Jun 30.
Autor:
Devarajan E; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1448, Houston, TX, 77030, USA., Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang WL; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jensen VB; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jayakumar A; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Leung CH; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin HY; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ihezie SA; McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA., Tsai JW; Department of Anatomic Pathology, E-Da Hospital, Kaohsiung, Taiwan., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lewis VO; Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1448, Houston, TX, 77030, USA. volewis@mdanderson.org.
Publikováno v:
Discover oncology [Discov Oncol] 2024 Jun 18; Vol. 15 (1), pp. 232. Date of Electronic Publication: 2024 Jun 18.
Autor:
Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lazar AJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Jun; Vol. 263 (2), pp. 131-134. Date of Electronic Publication: 2024 Mar 14.
Autor:
Fang H; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ibrahim AF; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA., Tang Z; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., You MJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu J; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Li S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yin CC; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., El Hussein S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Le N; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thakral B; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Thornton R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. wwang13@mdanderson.org.
Publikováno v:
Leukemia [Leukemia] 2023 Sep; Vol. 37 (9), pp. 1919-1921. Date of Electronic Publication: 2023 Jul 13.
Autor:
Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wu CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Nakazawa M; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ingram D; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Daniele JR; TRACTION Platform, Division of Therapeutics Discovery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Lazcano R; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Davies C; Research Department of Pathology, UCL Cancer Institute, London WC1E 6DD, UK., Daw NC; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wani K; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wang WL; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rubin B; Institute Chair, Cleveland Clinic, Cleveland, OH 44195, USA., Conley A; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Flanagan AM; Research Department of Pathology, UCL Cancer Institute, London WC1E 6DD, UK.; Royal National Orthopaedic Hospital NHS Trust, Stanmore, Middlesex HA7 4LP, UK., Lazar AJ; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
HGG advances [HGG Adv] 2023 Jul 19; Vol. 4 (4), pp. 100224. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Autor:
Khlebus E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vuttaradhi VK; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Welte T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Khurana N; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Celestino J; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Beird HC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Legarreta AF; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fellman BM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas., Nguyen T; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Lawson B; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ferri-Borgogno S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mok SC; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Broaddus RR; Department of Pathology and Laboratory Medicine, The University of North Carolina, Chapel Hill, North Carolina., Gershenson DM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hillman RT; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; CPRIT Scholar in Cancer Research, Houston, Texas.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2023 May 01; Vol. 21 (5), pp. 483-494.
Autor:
Beird HC; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bielack SS; Pediatric Oncology, Hematology, Immunology, Klinikum Stuttgart - Olgahospital, Stuttgart Cancer Center, Stuttgart, Germany., Flanagan AM; Research Department of Pathology, Cancer Institute, University College London, London, UK., Gill J; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Heymann D; Nantes Université, CNRS, UMR6286, US2B, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Livingston JA; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roberts RD; Center for Childhood Cancer, Nationwide Children's Hospital, Columbus, Ohio, USA., Strauss SJ; University College London Hospitals NHS Foundation Trust, University College London, London, UK., Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. rgorlick@mdanderson.org.; Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. rgorlick@mdanderson.org.
Publikováno v:
Nature reviews. Disease primers [Nat Rev Dis Primers] 2022 Dec 30; Vol. 8 (1), pp. 82. Date of Electronic Publication: 2022 Dec 30.